The aim of present study was to check the possible association of potential parental environmental exposures and maternal supplementation intake with the risk of nonsyndromic orofacial clefting (NSOC). A retrospective study comprised 499 cases and 480 controls was conducted in Heilongjiang Province. Chi-square analysis and unconditional multiple logistic regression were used in the study. The results showed that maternal history of fever and the common cold without fever (ORCL/P = 3.11 and 5.56, 95%CI: 1.67–5.82 and 2.96–10.47, ORCPO = 3.31 and 8.23, 95%CI: 1.58–6.94 and 4.08–16.95), paternal smoking and alcohol consumption (ORCL/P = 2.15 and 5.04, 95%CI: 1.37–3.38 and 3.00–8.46, ORCPO = 1.82 and 4.40, 95%CI: 1.06–3.13 and 2.50–7.74), maternal exposure to organic solvents, heavy metals, or pesticides (ORCL/P = 6.07, 5.67 and 5.97, 95%CI: 1.49–24.76, 1.34–24.09 and 2.10–16.98, ORCPO = 10.65, 7.28 and 3.48, 95%CI: 2.54–44.67, 1.41–37.63 and 1.06–11.46) and multivitamin use during the preconception period (ORCL/P = 0.06, 95%CI: 0.02–0.23, ORCPO = 0.06, 95%CI: 0.01–0.30) were associated with cleft lip or without cleft palate (CL/P) and cleft palate only (CPO). Maternal history of skin disease and negative life events (ORCL/P = 12.07 and 1.67, 95%CI: 1.81–80.05 and 1.95–2.67) were associated with CL/P. Some potential parental hazardous exposures during the periconception period and maternal use of multivitamins during the preconception period were associated with risk of NSOC.
Objectives: The aim of this study was to perform a histological evaluation of sonodynamic therapy (SDT) of hematoporphyrin monomethyl ether (HMME) on artificially induced periodontal disease in rats. Methods: Submerging ligatures were placed at the subgingival region of the first maxillary molar in rats. Eighty rats were randomly assigned into four groups: group 1 received no treatment; group 2 was subjected to 50 µg/mL HMME alone; group 3 was treated with low-intensity ultrasound alone (1 W/cm2); and group 4 was treated with 50 µg/mL HMME plus ultrasound irradiation (1 MHz, 30 minutes). Ten rats in each group were euthanized at 7 and 15 days, and periodontal tissue samples were taken for histological examination. Results: The animals treated by SDT showed less bone loss (P0.05). Conclusion: Our results suggest that HMME-mediated SDT can effectively alleviate the periodontal tissue destruction in artificially induced periodontitis in rats. Hence, SDT may have good clinic potential as a noninvasive treatment of periodontal diseases.
It has been found that >90% of oral cancer patients suffer from squamous cell carcinoma (SCC). The 5‑year survival rate of SCC is ~50%, despite the availability of different treatments. Sonodynamic therapy (SDT) has been developed as a novel therapy for cancer, resisting bacterial infection and inhibiting atherosclerotic plaque progression. The present study investigated the efficacy of hematoporphyrin monomethyl ether (HMME)‑mediated SDT on the A‑253 epidermoid cancer cell line. The cytotoxicity of HMME and the survival rate of cells following SDT were examined by the MTT assay. Apoptosis and necrosis of cells were detected using flow cytometry with Annexin V and propidium iodide (PI) staining, and fluorescence microscopy with Hoechst 33258 and PI staining. Intracellular reactive oxygen species (ROS) and Ca2+ levels were measured using a fluorescence microscope based on 2',7'‑dichlorofluorescein diacetate and fluo‑3/acetoxymethylester, respectively. Results of the MTT assay demonstrated that a lower concentration (<10 µg/ml) of HMME had no significant effect on the A‑253 cells, but SDT combined with ultrasonic treatment for 1 min and 10 µg/ml HMME decreased the cell survival rate by 27%. Flow cytometry analysis revealed that A‑253 cells in the SDT group had a higher rate of late apoptosis compared with the control group. Furthermore, fluorescence quantitation of apoptotic A‑253 cells demonstrated that the percentages of apoptotic cells were increased in the ultrasound and SDT group compared with those in the control group. In the present study, the ROS level in the SDT group was elevated compared with that in the control group. The Ca2+ levels were increased to 181.2 and 268.7% in the ultrasound and SDT groups, respectively, relative to the control group. Taken together, the findings of the present study demonstrated that HMME‑SDT significantly induces the apoptosis of A‑253 cells together with intracellular ROS generation and Ca2+ overload. Thus, HMME‑SDT may be a promising treatment option for patients with SCC.
Purpose: The aim of this study was to evaluate the efficacy of sonodynamic therapy (SDT) porphyromonas gingivalis induced periodontitis in rats with diabetes. Methods: Colony forming unit and the intracellular reactive oxygen species (ROS) of Pg (ATCC 33277) was detected. Periodontal disease was induced by orally administering Pg and placing ligatures around the cervix of the first maxillary molar. After 4 weeks, the rats were received three treatments: irrigation with sterile saline solution (control group); scaling and root planing (SRP) (SRP group) hypodermic injection of 40 μg/mL HMME with 3 W/cm2 low-intensity ultrasound irradiation every other day (1 MHz, 600 s) (SRP+SDT group). All rats were euthanized at 10 days postoperatively. The maxilla was taken for histological examination. The distance between the cementoenamel junction (CEJ) and the alveolar bone crest (ABC) was measured to access the level of alveolar bone. Results: When Pg was treated with ultrasound (3 W/cm2 for 10 min) at 40 μg/mL HMME concentration, 4.7 lg reduction in CFU in SDT (P<0.01). The intracellular ROS in SDT group had a significant difference in comparison with the control group (P<0.01). In the D group, the intragroup analysis revealed less bone loss in the SRP+SDT treatment than in the control and SRP treatment (P<0.05). Intergroup analysis (ND and D groups) showed a greater bone loss in the ND group treated with SRP compared to the D group treated with SRP+SDT. Conclusions: SDT was an effective adjuvant therapy to SRP on induced periodontitis in rats with diabetes.